4//SEC Filing
Benaim Ely 4
Accession 0001645113-21-000094
CIK 0001645113other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 5:29 PM ET
Size
10.1 KB
Accession
0001645113-21-000094
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Benaim Ely
Chief Medical Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2021-07-30$83.30/sh+651$54,228→ 29,795 total - Sale
Ordinary Shares
2021-08-02$149.38/sh−536$80,067→ 28,608 total - Sale
Ordinary Shares
2021-07-30$158.96/sh−651$103,483→ 29,144 total - Exercise/Conversion
Options to Buy Ordinary Shares
2021-07-30−651→ 3,253 totalExercise: $83.30Exp: 2029-07-30→ Ordinary Shares (651 underlying)
Footnotes (3)
- [F1]Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Fully vested as of the date hereof.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001632237
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 5:29 PM ET
- Size
- 10.1 KB